Suskind Dennis 4
4 · CME GROUP INC. · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
CME Group (CME) Director Dennis Suskind Receives Award — 645 Shares
What Happened
- Dennis Suskind, a director of CME Group Inc. (CME), was granted 645 shares of Class A common stock on 2026-06-25. The shares were issued at $225.00 per share for a total value of $145,125. This was an award/grant (reported as transaction code A) issued as director compensation, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-25; Price per share: $225.00; Total value: $145,125.
- Transaction type: Award/Grant (A) — acquisition through the CME Group Director Stock Plan.
- Shares are fully vested on grant (per footnote): no vesting conditions apply.
- Shares owned after the transaction: not specified in the filing.
- Filing date: 2026-06-29 — filed within the typical Form 4 reporting window (timely).
Context
- This award appears to be routine equity compensation for non-employee directors under CME’s Director Stock Plan and does not indicate a market sale or purchase by the director. Because the shares are fully vested at grant, there are no future service-based vesting conditions attached. Routine director awards are common and reflect compensation rather than a direct investment decision by the insider.
Insider Transaction Report
Form 4
Suskind Dennis
Director
Transactions
- Award
Common Stock Class A
[F1]2026-06-25$225.00/sh+645$145,125→ 3,344 total
Footnotes (1)
- [F1]Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.
Signature
/s/ Elizabeth Hensen, as Attorney-in-Fact for Dennis A. Suskind|2026-06-29